Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colon Cancer
Previstage(TM) GCC Colorectal cancer staging test featured in Expert Reviews article
September 16th, 2008
The Previstage(TM) GCC Colorectal Cancer Staging Test, recently launched by DiagnoCure Oncology Laboratories, a wholly owned subsidiary of DiagnoCure Inc., is featured in this month's issue of Expert Reviews in Molecular Diagnostics. The article, which was written by Dr. Scott A. Waldman and Dr. Alex Mejia, from Thomas Jefferson University, reports that Previstage(TM) GCC detects occult metastases in lymph nodes, identifying patients who may be at increased risk of developing recurrent disease and who could most benefit from adjuvant chemotherapy. The article discussed the limitations of the traditional microscopic method for the staging of colorectal cancer patients,...
Source: Cancer Weekly (2008-09-16)
|
